Recombinant Bovine Solute carrier family 25 member 33 (SLC25A33)

What is SLC25A33 and what is its primary function in mitochondria?

SLC25A33 is a mitochondrial carrier protein that functions as a specialized transporter for pyrimidine nucleotides across the inner mitochondrial membrane. It primarily mediates the import and export of pyrimidine nucleotides (uracil, thymine, and cytosine) in their di- and triphosphate forms through an antiport mechanism . This transport activity is critical for maintaining the nucleotide pool balance between mitochondrial and cytosolic compartments. SLC25A33 selectively transports uridine, thymidine, guanosine, cytosine, and inosine (deoxy)nucleoside di- and triphosphates, but notably does not transport adenine nucleotides . The protein may specifically import (deoxy)nucleoside triphosphates in exchange for intramitochondrial (deoxy)nucleoside diphosphates, thus providing essential precursors for de novo synthesis of mitochondrial DNA and RNA while simultaneously exporting products of their catabolism .

How does SLC25A33 contribute to mitochondrial genome maintenance?

SLC25A33 plays a crucial role in mitochondrial genome maintenance through its regulation of nucleotide transport. By ensuring adequate supply of pyrimidine nucleotides to the mitochondrial matrix, SLC25A33 supports mtDNA replication and transcription processes . Research has demonstrated that depletion of SLC25A33 leads to reduction in mitochondrial nucleotide levels, particularly UTP, and subsequent depletion of mitochondrial DNA . Conversely, overexpression of SLC25A33 has been associated with enhanced mitochondrial DNA maintenance and increased mitochondrial TTP levels . The transporter also participates in regulation of mitochondrial membrane potential and mitochondrial respiration, which are intricately connected to mtDNA integrity . Experimental evidence indicates that cellular pyrimidine imbalance can trigger mitochondrial DNA release, which requires SLC25A33 activity, suggesting its involvement in the mitochondrial response to metabolic stress .

What are the known regulatory mechanisms of SLC25A33 expression?

SLC25A33 expression is regulated by multiple hormonal and environmental factors. Studies have demonstrated that 17β-estradiol increases SLC25A33 mRNA expression, while co-treatment with TGFB1 protein results in decreased expression . Similarly, dihydrotestosterone (17β-hydroxy-5α-androstan-3-one) has been found to increase SLC25A33 expression . Environmental toxins such as 2,3,7,8-tetrachlorodibenzodioxine can both increase and decrease SLC25A33 expression depending on the experimental context and specific cell types . The protein is also regulated at the post-translational level, with evidence suggesting that SLC25A33 can be a substrate for mitochondrial proteases such as YME1L . Upon insulin (INS) or insulin-like growth factor 1 (IGF1) stimulation, SLC25A33 participates in regulating cell growth and proliferation by controlling mitochondrial DNA replication and transcription, which affects the ratio of mitochondria-to-nuclear-encoded components of the electron transport chain .

How can recombinant bovine SLC25A33 be effectively produced and purified for research purposes?

The production of recombinant bovine SLC25A33 typically involves bacterial expression systems, particularly Escherichia coli, followed by protein purification and reconstitution into liposomes for functional studies . The methodology involves several key steps:

• Cloning and Expression Vector Design: The SLC25A33 coding sequence should be optimized for bacterial expression and cloned into a suitable expression vector containing an inducible promoter (typically T7) and appropriate affinity tags (His-tag or GST-tag) for purification.

• Bacterial Transformation and Culture: The expression vector is transformed into an E. coli strain optimized for membrane protein expression (e.g., C41(DE3) or BL21(DE3)pLysS). Cultures are grown to mid-log phase before induction with IPTG under optimized conditions (typically 18-25°C for 16-24 hours to reduce inclusion body formation).

• Membrane Fraction Isolation: Bacterial cells are harvested and lysed using mechanical disruption methods such as sonication or high-pressure homogenization. The membrane fraction containing the recombinant SLC25A33 is isolated by differential centrifugation.

• Detergent Solubilization: The membrane proteins are solubilized using carefully selected detergents that maintain protein functionality. Common choices include n-dodecyl-β-D-maltoside (DDM) or digitonin.

• Affinity Chromatography: The solubilized protein is purified using affinity chromatography based on the incorporated tag. This is typically followed by size exclusion chromatography to enhance purity.

• Reconstitution into Liposomes: For functional studies, the purified SLC25A33 is reconstituted into liposomes by mixing with phospholipids and removing the detergent through dialysis or adsorbent beads .

The quality and functionality of the recombinant protein can be assessed through SDS-PAGE, Western blotting with specific antibodies, and transport assays using radiolabeled nucleotides to confirm carrier activity .

What methodologies are most effective for studying SLC25A33-mediated nucleotide transport?

Studying SLC25A33-mediated nucleotide transport requires specialized techniques that can accurately measure the movement of nucleotides across membranes. The following methodologies have proven most effective:

• Liposome Reconstitution Assays: The gold standard method involves reconstituting purified SLC25A33 into liposomes and measuring the uptake or exchange of radiolabeled nucleotides . This system allows for precise control of internal and external substrate concentrations and can define transport kinetics (Km and Vmax values).

• Isolated Mitochondria Transport Assays: Mitochondria isolated from cells expressing normal or altered levels of SLC25A33 can be used to measure nucleotide uptake using radiolabeled substrates.

• Nucleotide Pool Analysis: Liquid chromatography-mass spectrometry (LC-MS) can be employed to quantify changes in mitochondrial and cytosolic nucleotide pools in response to SLC25A33 manipulation.

• Patch-Clamp Electrophysiology: For detailed biophysical characterization, patch-clamp techniques can be applied to mitoplasts (mitochondria with the outer membrane removed) to measure SLC25A33-mediated currents.

• Fluorescent Nucleotide Analogs: Using fluorescently labeled nucleotide analogs can allow real-time visualization of transport in living cells using confocal microscopy.

• Transport Inhibition Studies: Transport assays in the presence of specific inhibitors of mitochondrial carriers (such as mercurial compounds) can help characterize the transport mechanism .

These methodologies have revealed that SLC25A33 transports uracil, thymine, and cytosine (deoxy)nucleotides with different efficiencies and primarily operates through an antiport mechanism, exchanging external nucleoside triphosphates for internal nucleoside diphosphates .

How does SLC25A33 contribute to immune signaling, and what experimental approaches can detect this activity?

SLC25A33 has been implicated in immune signaling through its role in mitochondrial DNA (mtDNA) release and subsequent activation of the cGAS-STING-TBK1 inflammatory pathway . This immune signaling function of SLC25A33 can be investigated using the following experimental approaches:

• Cytosolic mtDNA Detection:

  • qPCR analysis of cytosolic fractions to quantify mtDNA release

  • Immunofluorescence microscopy with DNA-specific dyes and mitochondrial markers to visualize mtDNA localization

  • PicoGreen staining of non-nuclear DNA combined with mitochondrial markers

• Immune Signaling Pathway Analysis:

  • Western blotting for phosphorylated STING, TBK1, and IRF3

  • Luciferase reporter assays for IFN-β promoter activity

  • qRT-PCR for interferon-stimulated genes (ISGs)

  • ELISA measurements of type I interferons in cell culture supernatants

• Genetic Manipulation Approaches:

  • SLC25A33 overexpression systems to induce immune signaling

  • CRISPR-Cas9 knockout or siRNA-mediated knockdown of SLC25A33

  • Rescue experiments in SLC25A33-depleted cells

  • Mutagenesis of critical transport residues to separate transport function from immune activity

• Metabolic Modulation:

  • Inhibition of de novo pyrimidine synthesis to induce pyrimidine deficiency

  • Nucleotide supplementation experiments to rescue phenotypes

  • Measurement of cellular pyrimidine pools using HPLC or LC-MS/MS

Research has demonstrated that overexpression of SLC25A33 is sufficient to induce immune signaling mediated by mtDNA, while cellular responses to pyrimidine deficiency require functional SLC25A33 to trigger mtDNA-dependent immune activation .

What techniques are recommended for studying SLC25A33 interactions with mitochondrial proteases?

Evidence suggests that SLC25A33 may be regulated by mitochondrial proteases such as YME1L . Investigating these interactions requires specialized approaches:

• Protein Stability Assays:

  • Cycloheximide chase experiments can reveal the degradation kinetics of SLC25A33 in cells with normal or depleted protease levels

  • Pulse-chase labeling with 35S-methionine to track protein turnover rates

• Protease-Substrate Co-Immunoprecipitation:

  • Pull-down assays using tagged versions of SLC25A33 and potential protease partners

  • Proximity labeling techniques such as BioID or APEX2 to identify proteins in close proximity to SLC25A33

• In Vitro Degradation Assays:

  • Purified components can be combined to test direct degradation of SLC25A33 by specific proteases

  • Time-course analysis of degradation products by SDS-PAGE and Western blotting

• Structural Analysis of Recognition Sites:

  • Mutagenesis of potential protease recognition sites in SLC25A33

  • Hydrogen-deuterium exchange mass spectrometry to identify regions of SLC25A33 accessible to proteases

• Mitochondrial Membrane Protein Complex Analysis:

  • Blue native PAGE to preserve membrane protein complexes

  • Complexome profiling combining native electrophoresis with mass spectrometry

Research using cycloheximide chase experiments has demonstrated increased stability of SLC25A33 in YME1L-deficient cells, suggesting it may be a substrate for this mitochondrial protease .

How can researchers assess the impact of SLC25A33 activity on mitochondrial function?

The impact of SLC25A33 on mitochondrial function can be comprehensively assessed using these methodological approaches:

• Mitochondrial Respiration Analysis:

  • Oxygen consumption rate (OCR) measurements using Seahorse XF analyzers

  • High-resolution respirometry with Oroboros instruments

  • Clark-type oxygen electrode measurements of isolated mitochondria

• Mitochondrial Membrane Potential:

  • Fluorescent probes such as TMRM, JC-1, or Rhodamine 123

  • Flow cytometry or confocal microscopy-based quantification

• Mitochondrial DNA Analysis:

  • qPCR to quantify mtDNA copy number

  • Long-range PCR to detect mtDNA deletions

  • Next-generation sequencing for comprehensive mtDNA integrity assessment

  • Fluorescence in situ hybridization for mtDNA visualization

• Reactive Oxygen Species Measurement:

  • Mitochondria-specific probes like MitoSOX Red

  • General ROS indicators such as DCF-DA

  • Electron paramagnetic resonance spectroscopy for specific radical detection

• Mitochondrial Protein Synthesis:

  • 35S-methionine labeling of newly synthesized mitochondrial proteins

  • Northern blotting or qRT-PCR for mitochondrial RNA levels

  • Ribosome profiling to assess translation efficiency

Research has shown that SLC25A33 knockdown leads to depletion of mtDNA, reduced oxidative phosphorylation, decreased cell size, lower mitochondrial UTP levels, and increased reactive oxygen species, while its overexpression enhances cell size, increases mitochondrial TTP levels, and diminishes reactive oxygen species .